期刊文献+

儿童难治性血细胞减少的临床特征分析 被引量:3

Clinical features of childhood refractory cytopenia
原文传递
导出
摘要 目的:研究儿童难治性血细胞减少(RCC)的临床特征。方法回顾性分析1990年1月到2013年6月1420例初诊为非重型再生障碍性贫血儿童(0-14岁)的临床资料,重新评估患儿骨髓细胞形态和组织病理,按照2008版WHO造血与淋巴组织肿瘤中RCC诊断标准重新进行诊断分型。患儿临床转归通过每3-6月门诊就诊随访获得。结果1420例患儿中,152例(10.7%)诊断为RCC。与非重型再生障碍性贫血患儿比较,RCC患儿发病时血红蛋白较低,胎儿血红蛋白比例增高。RCC患儿诊断时异常核型者比例为21.5%。中位随访时间为36个月(范围1-283个月)。RCC患儿对环孢素和雄激素治疗的完全有效、部分有效和无效率分别为19.0%、26.7%、54.3%。RCC患儿5年和10年的预期生存率分别为87.9%和72.4%;5年和10年的预期克隆演变率分别为15.3%和20.0%;2年预期新发染色体核型异常率为3.6%;5年和10年预期白血病转化率为10.0%和20.0%。结论 RCC具有成人骨髓增生异常综合征的基本特征。RCC患儿预后差,向白血病转化风险高,环孢素治疗有效率较低。 Objective To study the clinical features of patients with refractory cytopenia of childhood (RCC). Methods The clinical data of 1 420 children (0-14 years old) with an initial diagnosis of non-severe aplastic anemia between January 1990 and June 2013 were retrospectively analyzed. Bone marrow cell morphology and histopathology were re-evaluated, and the patients were re-classiifed using the criteria proposed in the 2008 edition of the World Health Organization classiifcation of RCC in hematopoietic and lymphoid tumor tissues. The clinical outcomes were followed up every 3-6 months. Results Among all the 1 420 cases, 152 (10.7%) were reassessed as RCC. Patients with RCC had a lower level of hemoglobin and a higher percentage of fetal hemoglobin than those with non-severe aplastic anemia. Of the patients with RCC, 21.5%showed abnormal karyotypes at diagnosis. The median follow-up period for all patients was 36 months (ranging from 1 to 283 months). The rates of complete response, partial response, and no response to cyclosporine and androgen treatment in RCC patients were 19.0%, 26.7%, and 54.3%, respectively. The 5-and 10-year prospective overall survival rates of RCC patients were 87.9%and 72.4%, respectively. The 5-and 10-year prospective clonal evolution rates were 15.3% and 20.0%, respectively. The 2-year prospective incidence of newly diagnosed karyotype abnormality after the initial diagnosis was 3.6%. The 5-and 10-year prospective leukemia transformation rates were 10.0%and 20.0%, respectively. Conclusions RCC shows clinical features similar to adult myelodysplastic syndrome. Children with RCC have a poor prognosis, an increased risk of transformation to leukemia, and a low response rate to cyclosporine treatment.
出处 《中国当代儿科杂志》 CAS CSCD 北大核心 2015年第1期15-21,共7页 Chinese Journal of Contemporary Pediatrics
基金 2010-2012卫生部部属(管)医院学科重点项目
关键词 难治性血细胞减少 临床特征 预后 儿童 Refractory cytopenia Clinical feature Prognosis Child
  • 相关文献

参考文献29

  • 1Baumann I, Niemeyer CM, Bennett JM, et al. WHO classification of tumors of haematopoietic and lymphoid tissues[M]//Swerdlow SH, Campo E, Harris Nl, et al. Childhood Myelodysplastic Syndrome, 2008: 104-107.
  • 2Niemeyer CM, Baumann I. Myelodysplastic syndrome in children and adolescents[J]. Semin Hematol, 2008, 45(1): 60-70.
  • 3Hasle H, Niemeyer CM, Chessells JM, et al. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases[J]. Leukemia, 2003, 17(2): 277-282.
  • 4Kardos G, Baumann I, Passmore SJ, et al. Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7[J]. Blood, 2003, 102(6): 1997-2003.
  • 5Incidence of aplastic anemia: the relevance of diagnostic criteria. By the International Agranulocytosis and Aplastic Anemia Study[J]. Blood, 1987, 70(6): 1718-1721.
  • 6谢晓恬,应大明.小儿再生障碍性贫血诊疗建议[J].中国小儿血液与肿瘤杂志,2007,12(5):236-240. 被引量:26
  • 7Yang W, Zhang P, Hama A, et al. Diagnosis of acquired bone marrow failure syndrome during childhood using the 2008 World Health Organization classification system[J]. Int J Hematol, 2012, 96(1): 34-38.
  • 8Baumann I, Führer M, Behrendt S, et al. Morphological differentiation of severe aplastic anaemia from hypocellular refractory cytopenia of childhood: reproducibility of histopathological diagnostic criteria[J]. Histopathology, 2012, 61(1): 10-17.
  • 9Niemeyer CM, Baumann I. Classification of childhood aplastic anemia and myelodysplastic syndrome[J]. Hematology Am Soc Hematol Educ Program, 2011, 2011: 84-89.
  • 10杨文钰,陈晓娟,张培红,滨麻人,伊藤雅文,小岛势二,竺晓凡.儿童血细胞减少伴骨髓增生减低100例临床特征分析[J].中国当代儿科杂志,2013,15(6):448-452. 被引量:4

二级参考文献22

  • 1-.首届中华血液学学会全国血栓与止血学术会议有关出凝血疾病的诊断标准(修订案)[J].中华血液学杂志,1987,8(30):183-183.
  • 2中华医学会第四届全国再生障碍性贫血学术会议纪要;再生障碍性贫血诊断标准[J].中华血液学杂志,1987,8:486-486.
  • 3中华医学会第四届全国再生障碍性贫血学术会议纪要;再生障碍性贫血疗效标准[J].中华血液学杂志,1987,8:4-4.
  • 4Rosenfeld S, Follman D, Nunez O, et al. Antithymocyte and cyclosporine for severe aplastic anemia:association between hematologic response and long-term outcome.JAMA. 2003,289:1130.
  • 5Camitta BM. A prospective study of the effect of androgen and bone marrowtraansplantation on treatment of severe aplastic anemia. Blood, 1979,53:504.
  • 6Scott C, Howard, Paula E, et al. Natural history of moderate aplastic anemia in children. Pediatr Blood Cancer,2004,43:545.
  • 7Teramura M, Kimura A, lwase S, et al. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults,a muhicenter randomized study in Japan. Blood, 2007 May 25.[ Epub ahead of print].
  • 8Bacigalupo A, Chaple M, Hows J, et al. Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (Mpred) with or without androgens. Br J Haematol, 1993,83:145.
  • 9BrodskyRA, Chen AR, Brodsky I, et al. High-dose cyclophosphamide as Salvage therapy for severe aplastie anemia. Exp Hematol,2004,32:435.
  • 10Camitta BM. A prospective study of the effect of early marrow trans- plantation on acute mortality.Blood,1976,48:63.

共引文献28

同被引文献23

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部